Literature DB >> 26216820

The Role of Postchemotherapy Surgery in Germ Cell Tumors.

Lisly Chéry1, Atreya Dash2.   

Abstract

Retroperitoneal lymph node dissection after chemotherapy has a proved role in the staging and treatment of metastatic testicular cancer. Complete removal of all postchemotherapy residual masses in nonseminomatous germ cell tumor should be performed. Complete removal of positron emission tomography-avid masses greater than 3 cm in pure seminoma should be performed. Outcomes depend on patient selection and extent of surgery.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Germ cell tumors; Lymph node dissection; Testicular cancer

Mesh：

Year:  2015        PMID： 26216820     DOI： 10.1016/j.ucl.2015.04.007

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  5 in total

1.  Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?

Authors:  C Overs; J B Beauval; L Mourey; P Rischmann; M Soulié; M Roumiguié; Nicolas Doumerc
Journal:  World J Urol       Date:  2018-01-20       Impact factor: 4.226

2.  Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.

Authors:  Roy Mano; Maria F Becerra; Brett S Carver; George J Bosl; Robert J Motzer; Dean F Bajorin; Darren R Feldman; Joel Sheinfeld
Journal:  J Urol       Date:  2016-10-05       Impact factor: 7.450

3.  Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection from a High-volume UK Centre Compared with a National Data Set.

Authors:  Adam Kieran Pearce; David Manson-Bahr; Alison Reid; Robert Huddart; Erik Mayer; David L Nicol
Journal:  Eur Urol Open Sci       Date:  2021-09-30

4.  Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections.

Authors:  Daniel E Spratt; Krithika Suresh; Takahiro Osawa; Matthew Schipper; William C Jackson; Ahmed Abugharib; Amir Lebastchi; David Smith; Jeffrey S Montgomery; Ganesh S Palapattu; L Priya Kunju; Angela Wu; Madelyn Lew; Scott A Tomlins; Arul M Chinnaiyan; Alon Z Weizer; Khaled S Hafez; Samuel D Kaffenberger; Aaron Udager; Rohit Mehra
Journal:  Med Oncol       Date:  2018-01-31       Impact factor: 3.064

Review 5.  Treatment of germ cell testicular cancer.

Authors:  Ana Koši Kunac; Milena Gnjidić; Zrna Antunac Golubić; Marija Gamulin
Journal:  Acta Clin Croat       Date:  2020-09       Impact factor: 0.780
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.